Showing results (541-550 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2025
SOHO State of the Art Updates and Next Questions: Treatment Options for Marginal Zone LymphomaMaria Cristina Pirosa, Anastasios Stathis, Davide Rossi, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2025
Matching-Adjusted Indirect Comparison of Daratumumab-Pomalidomide-Dexamethasone and Pomalidomide-Bortezomib-Dexamethasone in Relapsed/Refractory Multiple MyelomaWee Joo Chng, David Bin-Chia Wu, Cathy Kwang-Wei Wu, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 21, 2025
A Review of Real-World Experience With Ruxolitinib for MyelofibrosisHaifa Kathrin Al-Ali, Aaron T Gerds, Michael R Grunwald, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 1, 2025
Spot Urine Protein/Creatinine Ratio as an Alternative to 24-Hour Urine Collection for Measuring Proteinuria in Patients With Multiple Myeloma: A Prospective StudySaad Jamshed, Mohammad Ammad-Ud-Din, Kimberly Celotto, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2025
Multiple Myeloma in Italy: An Epidemiological Model by Treatment Line and Refractoriness StatusRoberto Mina, Silvia Mangiacavalli, Bernardo Rossini, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 6, 2024
The Impact of Clinical Features on Survival and Relapse of Patients Diagnosed With T-cell Acute Lymphoblastic Leukemia - a Multicenter Cohort StudyDiego Luz Felipe da Silva, Bruno Kosa Lino Duarte, Yve Cardoso de Oliveira, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2025
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative NeoplasmsJoseph Cannova, Shiv Shah, Anand A Patel
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2024
Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System ProphylaxisIzel Okcu, Yucai Wang, Allison M Bock, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 27, 2024
Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021Lars Henrik Dahl Hamnvik, Stella Eide-Olsen, Arne Fosseng, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2024
CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic SyndromeJoanne Lc Tan, David J Curtis, Jenny Muirhead, et al.
Pageof 251